Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 -0.0371106693174287
Stock impact report

Celldex prices $300M stock at $29 per share to fuel Barzolvolimab launch [Seeking Alpha]

Celldex Therapeutics, Inc. (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
Company Research Source: Seeking Alpha
Subscribe to Newsletters Sign Up Celldex Therapeutics ( CLDX priced an underwritten public offering of ~10.3M shares at a public offering price of $29.00 per share. All of the shares to be sold in the offering are to be sold by Celldex. The underwriters have Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
CLDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLDX alerts
Opt-in for
CLDX alerts

from News Quantified
Opt-in for
CLDX alerts

from News Quantified